Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-863-2013

Drug recall · August 21, 2013

Cidofovir Opthalmic Solution recall

Why: Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Cidofovir Opthalmic Solution, compounded by Pallimed Solutions Pharmacy, Woburn, MA

Lots / codes

All lots within expiry

Quantity
23 vials
Company
Pallimed Solutions, Woburn, MA
Distribution
Nationwide
Initiated
March 25, 2013 · Voluntary: Firm initiated
Classified
August 9, 2013
Reported
August 21, 2013
Ended
August 21, 2013
How notified
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Cidofovir

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.